Risk-first analysis for brand-new microcaps on Solana and Base — risk, market, and social, scored transparently in the first 0–48h. The analysis. Never a call.
Don't ape. Assay.
Hundreds of pools open every hour. Most are honeypots, rugs, or pumps gone before you blink — and the "alpha" channels just scream buy, then quietly bury their losers.
Honeypots, open mint authority, hidden sell taxes, whale-loaded supply. The contract lies — and the chart won't show it.
Call groups sell signals and survivorship bias. No track record, no control group, no one accountable when it dumps.
By the time a "call" reaches you, the move already happened — or the exit liquidity is already gone.
We don't tell you what to buy. We assay each coin — the way you test the purity of gold — and hand you the result.
We continuously index newly discovered pools on Solana and Base, then re-assay tracked tokens for up to 48 hours.
An anti-scam gate — honeypot, liquidity, taxes, holder concentration — feeds three transparent scores. No black-box theatre.
You get the full assay and make your own call. We never print "buy". That is the entire point of the product.
Anyone can shout a ticker. Almost no one will tell you whether their picks actually beat doing nothing. We do — and we measure it.
"Buy now. 100x guaranteed. Trust me, bro."
No method. No record. No control. No one to blame when the chart goes vertical the wrong way.
A transparent assay — and a public test of whether it has an edge.
Each flagged token is paper-traded pessimistically and compared with a control group. If the method does not beat the control, we publish that too.
You see the inputs, not a magic number. Here's what each part of an assay actually measures.
Honeypot, mint authority, sell tax, liquidity and holder checks. A higher score means fewer monitored risk signals were detected — not that the token is safe.
Liquidity depth, volume quality, and price structure — the things that decide whether you can actually get out.
Genuine attention versus manufactured noise. Bot clusters and recycled hype get discounted, not counted.
↳ Values shown are an illustrative sample — not a recommendation.
We paper-trade flagged tokens and compare outcomes with a control group under pessimistic fees, slippage and latency assumptions. The methodology and results will be published — positive, negative or inconclusive.
↳ Numbers will be published after data quality and sample-size review. Results will be public — positive, negative or inconclusive. Paper validation only. Not financial advice.
Assay is a research tool for people who already think for themselves — and want a sharper instrument.
Early-token traders who already check contracts, liquidity and holder concentration before entering
Crypto researchers tracking new launches
Small Discord / Telegram communities
People tired of call groups and survivorship bias
A working tool, not a waitlist. You get the dashboard while we validate in the open.
We review requests manually during private beta. Analysis only — not financial advice.
During beta, access is intentionally limited so we can validate the system, collect feedback and improve the product — without turning it into a noisy call group.
Fill the short form below so we understand who you are and what you trade or research.
We onboard founding users in small batches so feedback stays high-signal and the tool stays sharp.
You receive dashboard access and a direct line to the founder while we validate in the open.
No. Assay provides risk, market and social analysis. We do not tell you what to buy or sell.
Those tools are valuable data sources. Assay combines contract and liquidity screening with market and social context, follows newly discovered tokens through the first 48 hours, and tests its own flags against a control group.
No. Assay reports what it detects and what the data supports. The decision remains yours.
No. Crypto is extremely risky. Assay is a research tool, not financial advice.
Solana and Base during the private beta.
Private dashboard access, early token feed, and transparent risk/market/social scores.
We are validating the system with a small group before opening broader access.
Early, hands-on access for a small group. Tell us a little about you and we'll reach out if you're a fit.
If you're a fit for the private beta, we'll reach out with access details.